SIMCERE PHARMA_Providing professional financial news and data related to SIMCERE PHARMA, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SIMCERE PHARMA(02096.HK): PD-1/VEGF Bispecific Antibody SIM0689 Approved for Clinical Trials by NMPA

Tags：

SIMCERE PHARMA 02096.HK ClinicalTrialApproval

2026-06-12

SIMCERE PHARMA (02096.HK): SIM0613 (LRRC15 ADC) Receives NMPA Clinical Trial Approval

Tags：

SIMCERE PHARMA 02096.HK ClinicalTrialApproval

2026-05-06

SIMCERE PHARMA(02096.HK) will spend HKD 22.21 million to repurchase 1.88 million shares on Jan 20, 2026

Tags：

SIMCERE PHARMA 02096.HK

2026-01-21

Finance
Artini Holdings (00789.HK): Profit Warning, Expected Swing to Annual Net Loss of HK$9.6 Million to HK$10 Million
Finance
Pine Technology Holdings (01079.HK): Change of Independent Non-executive Director – Song Hongdong Succeeds Liu Haichao
Finance
Peking University Resources (00618.HK): Positive Profit Alert, Expected Annual Profit of RMB 1.4 Billion to RMB 1.8 Billion
Finance
Beijing Enterprises Water Group (00371.HK): Completes Issuance of RMB 1.2 Billion Medium-Term Notes with Coupon Rate of 1.82%
Finance
China Longyuan Power (00916.HK): Implementation of 2025 Equity Distribution, Final Dividend of RMB 0.625 per 10 Shares
Finance
Shenwan Hongyuan (06806.HK): Subsidiary’s RMB 3.6 Billion Corporate Bonds Listed on Shenzhen Stock Exchange
Finance
New Focus (00360.HK): Appointment of Hord Capital as Independent Financial Adviser
Finance
China Everbright Greentech (01257.HK): Entered Framework Agreements for Hazardous Waste Disposal Services Covering 2026 to 2028
Finance
Muyuan Co., Ltd. (02714.HK): Completes Corporate Name Change
Finance
CGII HLDGS (01940.HK): Completion of Loan Assignment

Scan QR Code

Download App